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1.1. Solid-phase synthesis of smac peptidomimetic libraries
The apoptotic mechanism ensures that multicellular organisms
can exert tight control over cell proliferation. Through an intrinsic
pathway as a response to intracellular damage, or an extrinsic
pathway involving death-receptor ligands, caspases are activated
to initiate the proteolysis that results in cell death. One of the dis-
tinguishing features of cancer is an ability to evade these signal-
ling pathways, resulting in the proliferation of malignant cells,
even when subjected to chemotherapy agents. One key mecha-
nism for avoiding apoptosis involves the inhibitors of apoptosis
(IAP) – proteins that sequester caspases through baculoviral IAP
repeat (BIR) domains and avoid the consequential proteolytic
degradation.
There are several forms of the IAP proteins, but XIAP is known
to be a key player in the suppression of caspase-9 and the
downstream proteins caspases-3 and -7. However, there are
endogenous proteins such as the second-mitochondria-derived
activator of caspase (smac) which can bind to IAP and thereby re-
lease caspases to hasten programmed cell death. A current target
of therapeutic investigation is smac mimetics – small molecules
that can bind to XIAP and activate caspases. Several such
agents are in early clinical development. Some agents are mimet-
ics of dimeric smac and can bind simultaneously to multiple IAP
BIR-domains. A recent paper describes the use of solid-phase
library synthesis to explore SAR around a novel smac mimetic
pharmacophore.1
These smac mimetics were based on the common N-terminal
peptide sequence (N-methyl)AVPI, and these libraries investigated
the effects of diverse substitution on the proline and phenylalanine
positions. In particular, the libraries employed the copper (I) cata-
lysed azide-alkyne cycloaddition (CuAAC) for proline functionalisa-
tion, and Suzuki coupling for modiﬁed phenylalanines.doi:10.1016/j.comche.2011.12.001
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CuAAC reaction
CuAAC is widely used in medicinal chemistry to generate
1,4-disubstituted triazoles in a reliable and regioselective fashion.
cis- and trans-4-Azidoprolines were prepared using literature
methods and incorporated into AVPI tetrapeptide sequences (1)
on solid support. Reactions conditions were optimised for the
CuAAC reaction allowing the efﬁcient production of a range of
triazole products. Ultimately 20 each of the cis and trans products
(2) were prepared and cleaved from the solid support using TFA.
Palladium-catalysed Suzuki cross-coupling allowed the derivatisa-
tion of the 3- and 4-iodophenylalanine AVPI tetrapeptides (3) to
give the biaryl products (4).
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Suzuki reaction
The library compounds were subjected to biological evaluation
by a measurement of their ability to potentiate effects of the
known apoptotic agent, staurosporine in a live/dead ﬂuorometric
assay conducted on HeLa cells. Peptides were administered at 30
or 60 lM concentration, and cell survival was ascertained. It was
not possible to derive SAR information, but it was clear that the
cis-triazoloprolines were more active that the trans-counterparts,
and triazoles derived from aliphatic alkynes appeared more active.
The Suzuki product biaryl derivatives seemed to be more potent
than the triazoles. Although the mode of action of these com-
pounds could not be deﬁnitively determined from this study, the
approach seems to justify the use of solid-phase library generation
as a method of generating new smac mimetics.2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
No papers this month.
2.2. Solution-phase synthesis
The synthesis of differentially-substituted 3,5-bis(arylami-
no)pyrazoles has not yet been documented. A recent report
describes the development of a novel and entirely combinatorial
synthesis of 3,5-bis(arylamino)pyrazoles relying on a simple
one-pot two-step operation.2
2.3. Scaffolds and synthons for combinatorial libraries
Chiral building blocks are valuable intermediates in the synthe-
ses of natural products and pharmaceuticals. A scalable chemoen-
zymatic route to chiral diketides has been developed. The approach
includes the general synthesis of a-substituted, b-ketoacyl
N-acetylcysteamine thioesters followed by a biocatalytic cycle in
which a glucose-fueled NADPH-regeneration system drives reduc-
tions catalysed by isolated modular polyketide synthase (PKS)
ketoreductases. Several biocatalytic reactions have been scaled
up to yield more than 100 mg of product, demonstrating the ability
of PKS enzymes to economically and greenly generate diverse
chiral building blocks on a preparative scale.3
2.4. Solid-phase supported reagents
A facile and expeditious solid-phase synthesis of libraries of
quinoxalines promoted on KF-alumina surface via tandemoxidation–condensation or condensation reactions has been re-
ported. The reaction protocol is operationally simple and mild,
and moreover, solvent-free reaction condition makes the reaction
procedure eco-friendly and economically viable.4
Ferrier rearrangement is a Lewis acid catalysed allylic rear-
rangement of glycals in the presence of alcohols to yield 2,3-unsat-
urated glycosides. A recent report shows that NaHSO4 supported
on silica gel catalyses the Ferrier rearrangement reaction of
3,4,6-tri-O-acetyl-D-glucal with alcohols and thiols to give the
corresponding 2,3-unsaturated glycosides in high anomeric selec-
tivity and good to excellent yield with short reaction times.5
2.5. Novel resins, linkers and techniques
Performing reactions under microwave irradiation can offer a
considerable advantage over conventional synthesis with rate
enhancements and cleaner products. A new microwave-assisted
method for the synthesis of functionalised chromones has been
developed allowing the generation of a chromone carboxamide
library. The method presents several advantages including opera-
tional simplicity, good performance, signiﬁcant reduction in reac-
tion time, less formation of by-products and easier work-up.6
Small-molecule microarrays are often limited by the require-
ment for each compound undergoing immobilisation to contain a
common functional group or by the need to prepare glass slides
containing photo-reactive groups. A generic strategy has been pre-
sented that allows any compound library to be immobilised. This
was achieved by printing a ﬂuorous-tagged photo-reactive
3-aryl-3-triﬂuoromethyldiazirine, which undergoes non-selective
insertion into compounds following UV-activation, onto ﬂuorous-
functionalised glass slides.7
The ﬂuorous-assisted synthesis of oligosaccharides using a phe-
nyl ether linker has been reported. The phenyl ether linker is stable
under both acidic and basic conditions but can be cleaved under
mildly acidic conditions after reduction to a vinyl ether. The utility
of the method was demonstrated by the synthesis of a
trisaccharide.8
Compounds containing heteroatom–heteroatom bonds are
regarded as ‘‘undesirable’’ in drug discovery projects possibly due
to their inherent fragility, as measured by low bond dissociation
energies (BDEs). However, many marketed drugs contain these
molecular moieties and it can therefore be argued that the drugs
have stronger bonds than generic organic compounds. In a recent
study, heteroatom–heteroatom BDEs for marketed drugs and
non-drugs were calculated using the Density Functional Theory,
and results indicated that low BDE is not the main factor behind
heteroatom–heteroatom compound exclusion from drug discovery
projects. A more plausible explanation is that their electron rich
nature leaves them susceptible to electrophilic attack in biochem-
ical assays.9
The ability to screen and identify new ligands for cell surface
receptors has been a long-standing goal as it might allow targeting
of pharmaceutically relevant receptors, such as integrins or G
protein coupled receptors. A recent report describes a method to
amplify hits from a library of PNA-tagged peptides. Human cells,
overexpressing either integrins or the CCR6 receptor, were treated
with a 10,000 member PNA-encoded peptide library, and extrac-
tion of the PNA tags from the cells’ surface was followed by a
PNA-tag to DNA translation and ampliﬁcation enabling decoding
of the tags via microarray hybridisation.10
2.6. Library applications
A library of thiazolo[3,2-a]pyridines has been prepared in high
yields using a multicomponent reaction between aromatic
aldehydes, 2-nitromethylenethiazolidine and nitriles containing
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and 2-phenylsulphonylacetonitrile). One of the compounds shows
promising anticancer activity across a range of cancer cell lines.11
Diversity-oriented synthesis of derivatives of the potent glyco-
sidase inhibitor lentiginosine has been achieved in an efﬁcient
and versatile way by two modular approaches on key intermedi-
ates. The indolizidine ring system was assembled through a
1,3-dipolar cycloaddition of a dihydroxylated pyrroline N-oxide
with 4-butenol. The 7-amino and 7-azido derivatives can be conju-
gated with functionalised chains by coupling, respectively, with an
amino acid, or an alkyne in copper-catalysed Huisgen
cycloadditions.12
Based on modiﬁcation of separate structural features of the
Vibrio cholerae quorum sensing signal, (S)-3-hydroxytridecan-
4-one (CAI-1), three focused compound libraries have been syn-
thesised and evaluated for biological activity. Modiﬁcations to
the acyl tail and a-hydroxy ketone typically provided agonists with
activities correlated to tail length and conservative changes to the
hydroxy ketone. From this collection of agonists a molecule was
identiﬁed which is among the most potent agonists reported to
date with an EC50 of 0.21 lM and is anticipated to serve as a valu-
able tool in the study of quorum sensing in Vibrio cholerae.13
A series of tyrphostin-like compounds have been synthesised
and screened for their activity against MM-1 (multiple myeloma)
cells and other cell lines representing this malignancy. Synthesis
was completed in solution-phase initially and then adopted to
solid-phase for generating a more diverse set of compounds. A
chemical library of variants of the tyrphostin compound was
generated, incorporating variability at two sites within the
molecule – 15 at the aldehyde site and six at the amine site to
make a total of 90 compounds.14
A new class of inhibitors of pancreatic cholesterol esterase
(CEase) based on ‘priviledged’ 5-benzylidenerhodanine and 5-ben-
zylidene-2,4-thiazolidinedione scaffolds has been described. A
small library of analogues containing a core amino acid in place
of the glycerol group of the lead structures, was prepared to
explore other potential binding interactions with CEase, and these
inhibited with IC50 values ranging from 1.44 to 85 lM.15
References
1. Le Quement ST, Ishoey M, Petersen MT, Thastrup J, Hagel G, Nielsen TE. Solid-
phase synthesis of smac peptidomimetics incorporating triazoloprolines and
biarylalanines. ACS Comb Sci 2011;13(6):667–75.
2. Degorce S, Jung FH, Harris CS, Koza P, Lecoq J, Stevenin A. Diversity-orientated
synthesis of 3,5-bis(arylamino)pyrazoles. Tetrahedron Lett 2011;52(50):6719–22.
3. Piasecki SK, Taylor CA, Detelich JF, Liu J, Zheng J, Komsoukaniants A. Employing
modular polyketide synthase ketoreductases as biocatalysts in the preparative
chemoenzymatic syntheses of diketide chiral building blocks. Chem Biol
2011;18(10):1331–40.
4. Paul S, Basu B. Synthesis of libraries of quinoxalines through eco-friendly tandem
oxidation–condensation or condensation reactions. Tetrahedron Lett
2011;52(49):6597–602.
5. Kinfe HH et al. NaHSO4 supported on silica gel: an alternative catalyst for Ferrier
rearrangement of glycals. Carbohydrate Res 2011;346(16):2528–32.
6. Cagide F, Reis J, Gaspar A, Borges F. Accelerating lead optimization of chromone
carboxamide scaold throughout microwave-assisted organic synthesis. Tetrahe-
dron Lett 2011;52(48):6446–9.
7. Vallès-Miret M, Bradley M. A generic small-molecule microarray immobilization
strategy. Tetrahedron Lett 2011;52(50):6819–22.
8. Tanaka H, Tanimoto Y, Kawai T, Takahashi T. A ﬂuorous-assisted synthesis of
oligosaccharides using a phenyl ether linker as a safety-catch linker. Tetrahedron
2011;67(51):10011–6.
9. Yu B, Reynisson J. Bond stability of the ‘‘undesirable’’ heteroatom–heteroatom
molecular moieties for high-throughput screening libraries. Eur J Med Chem
2011;46(12):5833–7.
10. Svensen N, Díaz-Mochón JJ, Bradley M. Decoding a PNA encoded peptide library
by pcr: the discovery of new cell surface receptor ligands. Chem Biol
2011;18(10):1284–9.11. Altug C, Burnett AK, Caner E, Dürüst Y, Elliott MC, Glanville RPJ, et al. An eﬃcient
one-pot multicomponent approach to 5-amino-7-aryl-8-nitrothiazolo3,2-apyri-
dines. Tetrahedron 2011;67(49):9522–8.
12. Cordero FM, Balkrishna SJ, Bhakuni BS, Kumar S. Diversity-oriented syntheses of
7-substituted lentiginosines. Tetrahedron 2011;67(49):9555–64.
13. Bolitho ME, Shi J, Decicco CP, Tebben AJ, Olson RE, Boy KM, et al. Small molecule
probes of the receptor binding site in the Vibrio cholerae CAI-1 quorum sensing
circuit. Bioorg Med Chem 2011;19(22):6906–18.
14. Peng Z, Pal A, Han D, Wang S, Maxwell D, Levitzki A, et al. Tyrphostin-like
compounds with ubiquitin modulatory activity as possible therapeutic agents for
multiple myeloma. Bioorg Med Chem 2011;19(23):7194–204.
15. Heng S, Tieu W, Hautmann S, Kuan K, Pedersen DS, Pietsch M, et al. New
cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaolds.
Bioorg Med Chem Lett 2011;19(24):7453–63.
Further reading
Papers on combinatorial chemistry or solid-phase synthesis from other
journals
Gerona-Navarro G, Gonzalez-Muniz R, Fernandez-Carvajal A, Gonzalez-Ros JM, Ferrer-
Montiel A, Carreno C, et al. Solid-phase synthesis of a library of amphipatic
hydantoins. Discovery of new hits for TRPV1 blockade. ACS Comb Sci
2011;13(5):458–65.
Vankova B, Krchnak V, Soural M, Hlavac J. Direct C–H arylation of purine on solid
phase and its use for chemical libraries synthesis. ACS Comb Sci
2011;13(5):496–500.
Landge KP, Oh JS, Pae AN, Park WK, Gong JY, Koh HY, et al. Synthesis and
biological evaluation of focused isoxazolylpiperidinylpiperazine library for
dopamine D3 and D4 receptor antagonists. Bull Korean Chem Soc 2011;32(7):
2449–52.
Gong Y-D, Min KH, Lee T. An eﬃcient solid-phase synthesis of a-1,2,3-triazol-
oamide derivatives via click chemistry. Bull Korean Chem Soc 2011;32(7):
2453–6.
Zhang H, Jin H, Ji L-Z, Tao K, Liu W, Zhao H-Y, et al. Design, synthesis, and bioactivities
screening of a diaryl ketone-inspired pesticide molecular library as derived from
natural products. Chem Biol Drug Des 2011;78(1):94–100.
Iyer P, Bajorath J. Representation of multi-target activity landscapes through target
pair-based compound encoding in self-organizing maps. Chem Biol Drug Des
2011;78(5):778–86.
Kodadek T. The rise, fall and reinvention of combinatorial chemistry. Chem Commun
(Cambridge, United Kingdom) 2011;47(35):9757–63.
Shen S, Zhang H, Yang W, Yu C, Yao C. One-pot combinatorial synthesis of
benzo[4,5]imidazo[1,2-a]thiopyrano[3,4-d]pyrimidin-4(3H)-one derivatives. Chin
J Chem 2011;29(8):1727–31.
Ruvo M, Sandomenico A, Tudisco L, De Falco S. Branched peptides for the modulation
of protein-protein interactions: more arms are better than one? Curr Med Chem
2011;18(16):2429–37.
Bi B, Huang RY-C, Maurer K, Chen C, Moeller KD. Site-selective, cleavable linkers:
quality control and the characterization of small molecules on microelectrode
arrays. J Org Chem 2011;76(21):9053–9.
Thorson MR, Goyal S, Schudel BR, Zukoski CF, Zhang GGZ, Gong Y, et al. A
microﬂuidic platform for pharmaceutical salt screening. Lab Chip 2011;11(22):
3829–37.
Wu D, Wu S-Z, Chen Q-D, Zhao S, Zhang H, Jiao J, et al. Facile creation of hierarchical
PDMS microstructures with extreme underwater superoleophobicity for anti-oil
application in microﬂuidic channels. Lab Chip 2011;11(22):3873–9.
Han C, Zhang J, Zheng M, Xiao Y, Li Y, Liu G. An integrated drug-likeness study for
bicyclic privileged structures: from physicochemical properties to in vitro ADME
properties. Mol Divers 2011;15(4):857–76.
Hao M, Li Y, Wang Y, Zhang S. A classiﬁcation study of human b3-adrenergic receptor
agonists using BCUT descriptors. Mol Divers 2011;15(4):877–87.
Ou L, Han S, Ding W, Jia P, Yang B, Medina-Franco JL, et al. Parallel synthesis of novel
antitumor agents: 1,2,3-triazoles bearing biologically active sulfonamide moiety
and their 3D-QSAR. Mol Divers 2011;15(4):927–46.
Thompson CM, Poole JL, Cross JL, Akritopoulou-Zanze I, Djuric SW. Small molecule
library synthesis using segmented ﬂow. Molecules (Basel, Switzerland)
2011;16(11):9161–77.
Svensen N, Diaz-Mochon JJ, Bradley M. Microarray generation of thousand-member
oligonucleotide libraries. PLoS One 2011;6(9):e24906.
Siegwart DJ, Whitehead KA, Nuhn L, Sahay G, Cheng H, Jiang S, et al. Combinatorial
synthesis of chemically diverse core–shell nanoparticles for intracellular delivery.
Proc Natl Acad Sci USA 2011;108(32):12996–3001.
Ou L, Shao Z, Chen W, Giulianotti MA, Houghten RA, Yu Y. Solid-phase synthesis of
2,3,5,6-tetrahydro-1H-imidazo[1,2-a]benzo[d][1,3]diazepines via Pd(OAc)2/
Cu(OAc)2-cocatalyzed cyclization. Synlett 2011;(15):2259–61.
Perdih P, Baskovc J, Dahmann G, Groselj U, Kocar D, Novak A, et al. Parallel synthesis
of 1-substituted 5-(5-oxopyrrolidin-3-yl)-1H-pyrazole-4-carboxamides. Synthe-
sis 2011;(17):2822–32.
